HAEMONETICS CORP - Common stock, $.01 par value per share (HAE)

CUSIP: 405024100

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common stock, $.01 par value per share
Shares outstanding
46,480,294
Total 13F shares
56,558,011
Share change
+530,747
Total reported value
$4,415,683,452
Put/Call ratio
88%
Price per share
$78.08
Number of holders
305
Value change
+$40,389,204
Number of buys
159
Number of sells
130

Quarterly Holders Quick Answers

What is CUSIP 405024100?
CUSIP 405024100 identifies HAE - HAEMONETICS CORP - Common stock, $.01 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) as of Q4 2024

As of 31 Dec 2024, HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) was held by 305 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,558,011 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, NEUBERGER BERMAN GROUP LLC, Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, T. Rowe Price Investment Management, Inc., STATE STREET CORP, Thrivent Financial for Lutherans, GEODE CAPITAL MANAGEMENT, LLC, and ROYCE & ASSOCIATES LP. This page lists 307 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.